Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2002, Vol 19, Issue 1
Abstract
Thrombotic thrombocytopenic purpura (TTP) is an uncommon multisystemic disorder, sometimes associated with predisposing conditions such as pregnancy, cancer, exposure to certain drugs, bone marrow transplantation and HIV infection. In adults, the hemolytic uremic syndrome (HUS) and TTP are clinically and pathologically indistinguishable, except for the severity of renal failure. An abnormal interaction between the vascular endothelium and platelets in certain organs leads to thrombosis, endothelial proliferation, minimal inflammation and microangiopathic hemolysis. The endothelial cell disturbance and apoptosis caused by a plasma factor as yet unidentified, may lead to the release of unusually large von Willebrand factor (ULvWF) polymers, which facilitate the deposition of platelet microthrombi. The recent findings of complete deficiency of the vWF-cleaving metalloprotease in the chronic/relapsing form of TTP, which is often familial, the neutralization of the enzyme by a specific autoantibody that develops transiently and tends to disappear during remission in the more common acute form of TTP, and the normal levels of the metalloprotease and absence of inhibitory antibodies in HUS
Authors and Affiliations
N. ANAGNOSTOPOULOS, A. TSAKRI
Cabrera sign indicating old myocardial infarction
No abstract available
Solitary bone cyst
No abstract available
Measuring the quality of life and the European health model
The purpose of this study is to discuss the European health model and explore its relevance to measurement and evaluation of quality of life. The notion of social quality is discussed and empirical evidence is presented...
Oι λοιμώξεις στην παιδική ηλικία<br /> ως προδιαθεσικοί παράγοντες χρόνιων νοσημάτων
Η διάκριση μεταξύ λοιμωδών και χρόνιων νοσημάτων δεν μπορεί να γίνει πάντα με σαφήνεια και η σύγχυση των ορίων επιτάθηκε όταν συνειδητοποιήθηκε ότι ορισμένα οξέα λοιμώδη νοσήματα δεν μεταπίπτουν απλώς σε χρόνια, αλλά αυξ...
The problem of viral resistance in chronic hepatitis B therapy
Available agents for the treatment of chronic HBV infection include interferon-alpha, the nucleoside analogues lamivudine, telbivudine, entecavir and the noucleotide analogue adefovir and tenofovir. When nucleoside-nucle...